Acadian Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,353
Closed -$686K 2021
2022
Q4
$686K Buy
3,353
+2,885
+616% +$729K ﹤0.01% 951
2022
Q3
$128K Buy
+468
New +$119K ﹤0.01% 1305
2022
Q2
Sell
-1,069
Closed -$221K 1905
2022
Q1
$221K Sell
1,069
-1,238
-54% -$204K ﹤0.01% 1192
2021
Q4
$411K Sell
2,307
-313
-12% -$61.7K ﹤0.01% 1058
2021
Q3
$539K Buy
+2,620
New +$514K ﹤0.01% 1023

Other funds holding SWAV

Acadian Asset Management's SWAV Position: Q1 2023 in Review

Acadian Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 3,353 shares — an estimated $686K sold.

Acadian Asset Management first reported a position in SWAV in Q3 2021 and held it in 5 quarters. The position peaked at $686K in Q4 2022. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

  • Acadian Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Acadian Asset Management sold 3,353 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $686K.
  • Acadian Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Acadian Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $686K in Q4 2022.
  • 381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on Acadian Asset Management's 13F filing for Q1 2023, filed 11 May 2023.